Annual Total Liabilities
$29.13 M
-$9.93 M-25.41%
December 31, 2022
Summary
- As of February 8, 2025, AMAM annual total liabilities is $29.13 million, with the most recent change of -$9.93 million (-25.41%) on December 31, 2022.
- During the last 3 years, AMAM annual total liabilities has risen by +$3.39 million (+13.16%).
Performance
AMAM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$29.10 M
-$466.00 K-1.58%
September 1, 2023
Summary
- As of February 8, 2025, AMAM quarterly total liabilities is $29.10 million, with the most recent change of -$466.00 thousand (-1.58%) on September 1, 2023.
Performance
AMAM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AMAM Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.4% | - |
| 3 y3 years | +13.2% | -89.3% |
| 5 y5 years | +13.2% | - |
AMAM Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.4% | at low | -25.5% | -3.7% |
| 5 y | 5-year | -89.3% | -11.6% | -89.3% | -28.1% |
| alltime | all time | -89.3% | -11.6% | -89.3% | -28.1% |
Ambrx Biopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $29.10 M(-1.6%) |
| Jun 2023 | - | $29.56 M(+5.5%) |
| Mar 2023 | - | $28.02 M(-3.8%) |
| Dec 2022 | $29.13 M(-25.4%) | $29.13 M(-25.3%) |
| Jun 2022 | - | $38.98 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $39.05 M(-85.7%) | - |
| Dec 2021 | - | $39.05 M(+86.6%) |
| Jun 2021 | - | $20.93 M(-92.3%) |
| Dec 2020 | $272.17 M(+957.4%) | - |
| Dec 2020 | - | $272.17 M |
| Dec 2019 | $25.74 M | - |
FAQ
- What is Ambrx Biopharma annual total liabilities?
- What is the all time high annual total liabilities for Ambrx Biopharma?
- What is Ambrx Biopharma annual total liabilities year-on-year change?
- What is Ambrx Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ambrx Biopharma?
What is Ambrx Biopharma annual total liabilities?
The current annual total liabilities of AMAM is $29.13 M
What is the all time high annual total liabilities for Ambrx Biopharma?
Ambrx Biopharma all-time high annual total liabilities is $272.17 M
What is Ambrx Biopharma annual total liabilities year-on-year change?
Over the past year, AMAM annual total liabilities has changed by -$9.93 M (-25.41%)
What is Ambrx Biopharma quarterly total liabilities?
The current quarterly total liabilities of AMAM is $29.10 M
What is the all time high quarterly total liabilities for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly total liabilities is $272.17 M